机译:阴茎阶段I-III鳞状细胞癌患者的条件存活:癌症特异性死亡率的时间变化
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
2grid.15667.330000 0004 1757 0843Department of UrologyEuropean Institute of OncologyMilanItaly;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
8grid.4708.b0000 0004 1757 2822Department of Urology IRCCS Fondazione Ca’ Granda-Ospedale Maggiore;
9grid.22937.3d0000 0000 9259 8492Department of UrologyMedical University of ViennaViennaAustria;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
3grid.7637.50000000417571846Urology Unit ASST Spedali Civili of Brescia Department of Medical and;
2grid.15667.330000 0004 1757 0843Department of UrologyEuropean Institute of OncologyMilanItaly;
1grid.14848.310000 0001 2292 3357Cancer Prognostics and Health Outcomes UnitUniversity of Montreal;
Penile neoplasms; Squamous cell carcinoma; Mortality; SEER program;
机译:阴茎阶段I-III鳞状细胞癌患者的条件存活:癌症特异性死亡率的时间变化
机译:阴茎鳞状细胞癌患者疾病复发后癌症特异性死亡率预测
机译:基于人口的婚姻状况对阴茎鳞状细胞癌患者总体死亡率和癌症特异性死亡率影响的分析
机译:III期支气管内鳞状细胞癌:Nd:YAG激光联合光动力治疗与单独Nd:YAG激光或光动力治疗相比生存率
机译:通过差异显示(EDD)鉴定的E3连接酶可增强上皮性卵巢癌和口腔鳞状细胞癌的细胞存活率和顺铂耐药性。
机译:C反应蛋白与白蛋白前比(CPR):预测可切除食管鳞状细胞癌患者的癌症特异性生存率(CSS)和总体生存率(OS)的新型炎症-营养预后因素。
机译:KI-67,迷你染色体维持2蛋白(MCM2)和GEMININ对阴茎的手术治疗的鳞状细胞癌中的癌症特异性存活没有独立的预后相关性